Jennifer Flynn, based in Boston, MA, US, is currently a Oncology Senior Director and Early Oncology Scientific Lead, Global Evidence and Value Development at EMD Serono, Inc., bringing experience from previous roles at EMD Serono, Inc. and Eli Lilly and Company. Jennifer Flynn holds a University of North Carolina at Chapel Hill. With a robust skill set that includes Pharmaceutical Industry, Oncology, Neuroscience, Outcomes Research, Health Policy and more, Jennifer Flynn contributes valuable insights to the industry. Jennifer Flynn has 4 emails and 3 mobile phone numbers on RocketReach.